|
Published: January 18, 2010
It took a talking duck to make one of the
largest insurance companies rise from obscurity to one of the
most recognized names in the business.
Aflac Inc. (NYSE: AFL) provides health insurance for 40
million people worldwide and has received numerous awards for
being the best-managed and most ethical company in the insurance
category. It should have one more award to its name: The most
investor-friendly insurance company.
Growth-, income- and value-oriented investors will all find
something to love about Aflac. It has increased earnings per
share for 18 consecutive years. It has increased its dividend
payments for 26 straight years. And it trades at a -40% discount
to its historical valuation.
Aflac sells supplemental insurance in the two largest insurance
markets, Japan and the United States. Supplemental insurance is
designed to pay for out-of-pocket expenses not covered by
primary insurance policies. Aflac is offered to employees at the
work place, usually at no cost to the employer. Its
workplace-based distribution system reduces the cost of
acquiring customers.
Aflac is based in the United States but generates 72% of its
revenue in Japan. The company provides insurance for 89% of the
2,334 companies listed on the Tokyo Stock Exchange and is the
number one provider of health insurance in Japan. During the
past five years, Aflac has increased operating income, which
excludes income from investing activities, in its Japan branch
to $2.2 billion from $1 billion, a +17% annualized growth rate.
Aflac's presence is not as large in the United States, but it's
growing.
More than 450,000 U.S. companies offer Aflac to their employees.
But there is still plenty of room to grow -- only 6% of small
businesses currently offer Aflac. Operating income has increased
to $745 million from $451 million during the past five years, a
+10.5% annualized growth rate. Not bad considering the weak
economic conditions.
The main culprit has been the economy. High unemployment has
reduced the size of Aflac's customer base. And people who did
have jobs were less likely to purchase additional insurance amid
a recession.
The bearish stock market in the latter part of 2008 into early
2009 resulted in investment losses for Aflac, along with most
insurance companies. Premiums paid by policyholders are usually
invested to generate additional income. Slumping share prices
reduced the value of those investments, forcing insurance
companies to write-down assets, or lower the book value of their
assets to reflect current market prices.
The stock market has obviously improved during the last year,
and the worst seems to be in the rear view mirror. Aflac's
investment losses were -$226 million in the third quarter ended
September 30, 2009, compared with -$389 million in the
year-earlier period.
Two key factors set Aflac apart from most U.S. health insurance
companies. For one, since the bulk of Aflac's revenue comes from
its operations in Japan, any negative impact from a U.S. health
care bill on the insurance industry likely wouldn't cut as
deeply.
Second, Aflac focuses on selling insurance to protect policy
holders from loss of income due to an accident or illness. The
U.S. government already has programs in place to cover lost
income, such as Supplemental Security Income program and Social
Security Disability program.
However, the payments are usually not enough to cover medical
and everyday expenses associated with unemployment. In fact,
medical expenses cause about 62% of all bankruptcies in the
United States, and three-quarters of those who cite medical
expenses as the cause have health insurance. Obviously, there's
still a need for supplemental insurance.
Since most of Aflac's revenue stems from Japan, the shares can
serve as a currency
hedge against a falling dollar. In the third-quarter, the
average yen/dollar exchange rate fell -15% compared with the
third-quarter of 2008. That means earnings looked more
impressive in dollar terms since the dollar was cheaper in yen
terms.
Aflac's shares pay a $0.28 quarterly dividend per share for a
yield of 2.3%. Its long history of increasing earnings has
allowed it to raise dividend payments for 26 consecutive years.
The dividend has grown at an annualized growth rate of +24% for
the past five years.
Shares of Aflac have risen +27.8% during the past year, compared
with +33.9% for the S&P. During the past five years, however,
shares of Aflac have outperformed the S&P by +34.4%.
That doesn't mean the shares are expensive. Aflac's shares are
trading at an earnings multiple of 9.2, a steep -40% discount to
their five-year average earnings multiple of 15.3. Now could be
a great opportunity to buy shares of a great insurance company
at a discount.
-- Francisco Bermea
Staff Writer
Street
Authority |